Blockchain Registration Transaction Record

Ocumetics Strengthens Balance Sheet with $1.4M Debt Conversion

Ocumetics Technology Corp. converts $1.4M debenture principal to shares, reducing debt by 35% and strengthening balance sheet ahead of FDA IDE submission and patient study milestones.

This news matters because Ocumetics is developing a potentially revolutionary intraocular lens that could free millions from glasses or contacts. The debt conversion improves the company's financial health, reducing risk for investors and increasing the likelihood of successful clinical trials and FDA approval. For patients, this brings closer a future where clear vision at all distances is possible without corrective lenses, enhancing quality of life.